Enviomycin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IM |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H43N13O10 |
Molar mass | 685.69 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]
References
- ↑ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
- ↑ Selvakumar, N; Kumar, V; Acharyulu, GS; Rehman, F; Paramasivan, CN; Prabhakar, R (1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian journal of medical research. 95: 101–4. PMID 1506058.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.